We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Jacobs (JEC) Secures IDIQ Contracts From FBI in Washington DC
Read MoreHide Full Article
Jacobs Engineering Group Inc. has won two indefinite delivery, indefinite quantity (“IDIQ”) contracts from the Federal Bureau of Investigation (“FBI”) to offer architectural, engineering and planning services for one base year and four option years.
The FBI has awarded a pair of multiple-award contracts for the above-mentioned services for the bureau’s construction projects in Region 1 and 2. Notably, Region 1 covers the Washington, DC metropolitan area and global support, while Region 2 comprises Huntsville, AL. Among the various contractors assigned for the project, Jacobs was the only company to win in both the regions.
Solid Project Execution Bodes Well
Efficient project execution has been one of the main characteristics driving Jacobs’ performance over the last few quarters. This is evident from the company’s fiscal first-quarter 2019 backlog. Backlog (excluding discontinued business ECR) grew 8% year over year to $20.3 billion. Higher-margin Aerospace, Technology and Nuclear (ATN), and Buildings, Infrastructure and Advanced Facilities (BIAF) line of businesses continue to see a robust pipeline of government and infrastructure spending programs.
Notably, the BIAF business (accounting for 66.4% of fiscal first-quarter revenues) reported revenues of $2,048.8 million, which increased an impressive 90.9% year over year. Backlog in the segment also increased 7.4% from the prior-year quarter.
Also, its ATN segment, representing 33.6% of the total revenues, surged 45.6% in the fiscal first quarter. Moreover, backlog at the end of the quarter grew 7.8% year over year.
The company anticipates adjusted EPS in fiscal 2019 within $4.40-$4.80 and the same to be more than $5.00 in fiscal 2020. Moreover, the company projects three-year net organic revenues to witness a 3-5% CAGR, with BIAF leading the way with 4-6% top-line CAGR and ATEN with 2-3% CAGR.
Share Price Performance
Jacobs’ shares have outperformed its industry in the past year. The company’s shares have gained 27% compared with 2.2% growth of its industry in the said period. Its price performance is backed by an impressive earnings surprise history, having surpassed the Zacks Consensus Estimate in five of the trailing six quarters.
Zacks Rank & Stocks to Consider
Currently, Jacobs carries a Zacks Rank #5 (Strong Sell).
Apergy, Quanta Services and AECOM’s earnings for the current year are expected to increase 2.1%, 25.3% and 2.6%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better. See these 7 breakthrough stocks now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Jacobs (JEC) Secures IDIQ Contracts From FBI in Washington DC
Jacobs Engineering Group Inc. has won two indefinite delivery, indefinite quantity (“IDIQ”) contracts from the Federal Bureau of Investigation (“FBI”) to offer architectural, engineering and planning services for one base year and four option years.
The FBI has awarded a pair of multiple-award contracts for the above-mentioned services for the bureau’s construction projects in Region 1 and 2. Notably, Region 1 covers the Washington, DC metropolitan area and global support, while Region 2 comprises Huntsville, AL. Among the various contractors assigned for the project, Jacobs was the only company to win in both the regions.
Solid Project Execution Bodes Well
.jpg)
Efficient project execution has been one of the main characteristics driving Jacobs’ performance over the last few quarters. This is evident from the company’s fiscal first-quarter 2019 backlog. Backlog (excluding discontinued business ECR) grew 8% year over year to $20.3 billion. Higher-margin Aerospace, Technology and Nuclear (ATN), and Buildings, Infrastructure and Advanced Facilities (BIAF) line of businesses continue to see a robust pipeline of government and infrastructure spending programs.
Notably, the BIAF business (accounting for 66.4% of fiscal first-quarter revenues) reported revenues of $2,048.8 million, which increased an impressive 90.9% year over year. Backlog in the segment also increased 7.4% from the prior-year quarter.
Also, its ATN segment, representing 33.6% of the total revenues, surged 45.6% in the fiscal first quarter. Moreover, backlog at the end of the quarter grew 7.8% year over year.
The company anticipates adjusted EPS in fiscal 2019 within $4.40-$4.80 and the same to be more than $5.00 in fiscal 2020. Moreover, the company projects three-year net organic revenues to witness a 3-5% CAGR, with BIAF leading the way with 4-6% top-line CAGR and ATEN with 2-3% CAGR.
Share Price Performance
Jacobs’ shares have outperformed its industry in the past year. The company’s shares have gained 27% compared with 2.2% growth of its industry in the said period. Its price performance is backed by an impressive earnings surprise history, having surpassed the Zacks Consensus Estimate in five of the trailing six quarters.
Zacks Rank & Stocks to Consider
Currently, Jacobs carries a Zacks Rank #5 (Strong Sell).
Some better-ranked stocks in the Zacks Construction sector include Apergy Corporation , Quanta Services, Inc. (PWR - Free Report) and AECOM (ACM - Free Report) . While Apergy and Quanta Services sport a Zacks Rank #1 (Strong Buy), AECOM carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Apergy, Quanta Services and AECOM’s earnings for the current year are expected to increase 2.1%, 25.3% and 2.6%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>